Abstract |
Since several different pathways are involved in cerebral ischemia/ reperfusion injury, combination therapy rather than monotherapy may be required for efficient neuroprotection. In this study, we examined the protective effects of an apoptosis inhibitor Gly(14)-humanin (HNG) and a necroptosis inhibitor necrostatin-1 (Nec-1) on hypoxia/ ischemia/reperfusion injury. Cultured mouse primary cortical neurons were incubated with Nec-1, HNG or both in a hypoxia chamber for 60 min. Cell viability was determined by MTS assay at 24h after oxygen- glucose deprivation (OGD) treatment. Mice underwent middle cerebral artery occlusion for 75 min followed by 24h reperfusion. Mice were administered HNG and/or Nec-1 (i.c.v.) at 4h after reperfusion. Neurological deficits were evaluated and the cerebral infarct volume was determined by TTC staining. Nec-1 or HNG alone had protective effects on OGD-induced cell death. Combined treatment with Nec-1 and HNG resulted in more neuroprotection than Nec-1 or HNG alone. Treatment with HNG or Nec-1 reduced cerebral infarct volume from 59.3 ± 2.6% to 47.0 ± 2.3% and 47.1 ± 1.5%, respectively. Combined treatment with HNG and Nec-1 improved neurological scores and decreased infarct volume to 38.6 ± 1.5%. In summary, we demonstrated that the combination treatment of HNG and Nec-1 conferred synergistic neuroprotection on hypoxia/ ischemia/reperfusion injury in vitro and in vivo. These findings provide a novel therapeutic strategy for the treatment of stroke by combining anti-apoptosis and anti-necroptosis therapy.
|
Authors | Xingshun Xu, Kao-Wei Chua, Chu C Chua, Chun-Feng Liu, Ronald C Hamdy, Balvin H L Chua |
Journal | Brain research
(Brain Res)
Vol. 1355
Pg. 189-94
(Oct 08 2010)
ISSN: 1872-6240 [Electronic] Netherlands |
PMID | 20682300
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Copyright | Copyright © 2010 Elsevier B.V. All rights reserved. |
Chemical References |
- Imidazoles
- Indoles
- Intracellular Signaling Peptides and Proteins
- Neuroprotective Agents
- humanin
- necrostatin-1
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Cells, Cultured
- Disease Models, Animal
- Drug Synergism
- Drug Therapy, Combination
(methods)
- Hypoxia-Ischemia, Brain
(drug therapy, pathology, physiopathology)
- Imidazoles
(pharmacology, therapeutic use)
- Indoles
(pharmacology, therapeutic use)
- Intracellular Signaling Peptides and Proteins
(pharmacology, therapeutic use)
- Mice
- Neuroprotective Agents
(pharmacology, therapeutic use)
- Reperfusion Injury
(drug therapy, pathology, physiopathology)
- Signal Transduction
(drug effects, physiology)
- Treatment Outcome
|